Effects of topical nonsteroidal antiinflammatory drugs on the expression of matrix metalloproteinases in the cornea

Journal of Cataract and Refractive Surgery

Volumn 29, Issue 5, 2003, Pages 989-997

  Reviglio, Victor E ^b   Rana, Tayyib S ^b   Li, Qian J ^b   Ashraf, M Farooq ^b   Daly, Mary K ^b   O'Brien, Terrence P ^a  

^a JOHNS HOPKINS UNIVERSITY   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ARTIFICIAL TEAR; DICLOFENAC; MATRIX METALLOPROTEINASE; NONSTEROID ANTIINFLAMMATORY AGENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CALCIUM TRANSPORT; CATALYSIS; CONTROLLED STUDY; CORNEA CELL; CORNEA DISEASE; CORNEA EPITHELIUM; CYTOTOXICITY; DRUG EFFECT; ENZYME LOCALIZATION; ENZYME SUBSTRATE; EPITHELIUM CELL; FEMALE; IMMUNOHISTOCHEMISTRY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; WESTERN BLOTTING;

EID: 0038441687     PISSN: 08863350     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0886-3350(02)01737-6     Document Type: Article

References (39)

1. Fini ME, Parks WC, Rinehart WB, et al. Role of matrix metalloproteinases in failure to re-epithelialize after corneal injury. Am J Pathol 1996; 149:1287-1302
2. Fini ME, Yue BYJT, Sugar J. Collagenolytic/gelatinolytic metalloproteinases in normal and keratoconus corneas. Curr Eye Res 1992; 11:849-862
3. Ye HQ, Azar DT. Expression of gelatinases A and B, and TIMPs 1 and 2 during corneal wound healing. Invest Ophthalmol Vis Sci 1998; 39:913-921
4. Kreis T, Vale R. Guidebook to the Extracellular Matrix, Anchor, and Adhesion Proteins. Oxford, Oxford University Press, 1999
5. Massova I, Kotra LP, Fridman R, et al. Matrix metalloproteinases: structures, evolution, and diversification. FASEB J 1998; 12:1075-1095
6. Birkedal-Hansen H, Moore WG, Bodden MK, et al. Matrix metalloproteinases: a review. Crit Rev Oral Biol Med 1993; 4:197-250
7. Vane JR. Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs. Nat New Biol 1971; 231:232-235
8. Vane JR, Bakhle YS, Botting RM. Cyclooxygenases 1 and 2. Annu Rev Pharmacol Toxicol 1998; 38:97-120
9. Lu KL, Wee WR, Sakamoto T, McDonnell PJ. Comparison of in vitro antiproliferative effects of steroids and nonsteroidal antiinflammatory drugs on human keratocytes. Cornea 1996; 15:185-190
10. Haws MJ, Kucan JO, Roth AC, et al. The effects of chronic ketorolac tromethamine (Toradol) on wound healing. Ann Plast Surg 1996; 37:147-151
11. Dvivedi S, Tiwari SM, Sharma A. Effect of ibuprofen and diclofenac sodium on experimental wound healing. Indian J Exp Biol 1997; 35:1243-1245
12. Shimazaki J, Saito H, Yang H-Y, et al. Persistent epithelial defect following penetrating keratoplasty: an adverse effect of diclofenac eye drops. Cornea 1995; 14:623-627
13. Tomas-Barberan S, Fagerholm P. Influence of topical treatment on epithelial wound healing and pain in the early postoperative period following photorefractive keratectomy. Acta Ophthalmol 1999; 77:135-138
14. Donnenfeld ED, Selkin BA, Perry HD, et al. Controlled evaluation of a bandage contact lens and a topical nonsteroidal anti-inflammatory drug in treating traumatic corneal abrasions. Ophthalmology 1995; 102:979-984
15. O'Brien TP, Li QJ, Sauerburger F, et al. The role of matrix metalloproteinases in ulcerative keratolysis associated with perioperative diclofenac use. Ophthalmology 2001; 108:656-659
16. Schoenwald RD. Ocular pharmacokinetics. In: Zimmerman TJ, ed, Textbook of Ocular Pharmacology. Philadelphia, PA, Lippincott-Raven, 1997; 119-138
17. Burstein NL. Corneal cytotoxicity of topically applied drugs, vehicles and preservatives. Surv Ophthalmol 1980; 25:15-30
18. Gasset AR, Ishii Y, Kaufman HE, Miller T. Cytotoxicity of ophthalmic preservatives. Am J Ophthalmol 1974; 78: 98-105
19. Baudouin C. Side effects of antiglaucomatous drugs on the ocular surface. Curr Opin Ophthalmol 1996; 7(2):80-86
20. Becquet F, Goldschild M, Moldovan MS, et al. Histopathological effects of topical ophthalmic preservatives on rat corneoconjunctival surface. Curr Eye Res 1998; 17: 419-425
21. 2 on wound healing in rats. Ann Clin Lab Sci 1996; 26:451-457
22. Vane JR, Botting RM. Anti-inflammatory drugs and their mechanism of action. Inflamm Res 1998; 47(suppl 2):S78-S87
23. Whittle BJR, Higgs GA, Eakins KE, et al. Selective inhibition of prostaglandin production in inflammatory exudates and gastric mucosa. Nature 1980; 284:271-273
24. Dubois RN, Abramson SB, Crofford L, et al. Cyclooxygenase in biology and disease. FASEB J 1998; 12:1063-1073
25. Showell HJ, Pettipher ER, Cheng JB, et al. The in vitro and in vivo pharmacologic activity of the potent and selective leukotriene B4 receptor antagonist CP-105696. J Pharmacol Exp Ther 1995; 273:176-184
26. Wiggins RE, Jafri MS, Proia AD. 12(S)-hydroxy-5,8,10,14-eicosatetraenoic acid is a more potent neutrophil chemoattractant than the 12(R) epimer in the rat cornea. Prostaglandins 1990; 40:131-141
27. Kitaoji H, Kitaoji S, Nakai Y. [Diclofenac sodium ophthalmic solution before and after cataract surgery]. [Japanese] Rinsho Ganka 1991; 45:171-174
28. Takahashi N, Miyakoshi M, Taka N, et al. [Cytotoxic effects of diclofenac sodium]. [Japanese] Nippon Ganka Gakkai Zasshi 1993; 97:145-149
29. 2 subtype. Invest Ophthalmol Vis Sci 1991; 32:360-365
30. Sun R, Gimbel HV. Effects of topical ketorolac and diclofenac on normal corneal sensation. J Refract Surg 1997; 13:158-161
31. Chen X, Gallar J, Belmonte C. Reduction by antiinflammatory drugs of the response of corneal sensory nerve fibers to chemical irritation. Invest Ophthalmol Vis Sci 1997; 38:1944-1953
32. Aragona P, Tripodi G, Spinella R, et al. The effects of the topical administration of non-steroidal anti-inflammatory drugs on corneal epithelium and corneal sensitivity in normal subjects. Eye 2000; 14:206-210
33. Dinge JT. The effect of NSAID on human articular cartilage glycosaminoglycan synthesis. Eur J Rheumatol Inflamm 1996; 16:47-52
34. 1 inhibits collagenase gene expression in rabbit synoviocytes and human fibroblasts. Endocrinology 1992; 131:21-28
35. Fini ME, Girard MT, Matsubara M. Collagenolytic/gelatinolytic enzymes in corneal wound healing. Acta Ophthalmol Suppl 1992; 202:26-33
36. Garrana RMR, Zieske JD, Assouline M, Gipson IK. Matrix metalloproteinases in epithelia from human recurrent corneal erosion. Invest Ophthalmol Vis Sci 1999; 40:1266-1270
37. Flach A. Topically applied nonsteroidal anti-inflammatory drugs and corneal problems: an interim review and comment [editorial] . Ophthalmology 2000; 107:1224-1226
38. Lin JC, Rapuano CJ, Laibson PR, et al. Corneal melting associated with use of topical nonsteroidal anti-inflammatory drugs after ocular surgery. Arch Ophthalmol 2000; 118:1129-1132
39. Congdon NG, Schein OD, von Kulajta P, et al. Corneal complications associated with topical ophthalmic use of nonsteroidal antiinflammatory drugs. J Cataract Refract Surg 2001; 27:622-631